Company Filing History:
Years Active: 2012
Title: Matías Antonio Ávila Zaragozá: Innovator in Biomedical Research
Introduction
Matías Antonio Ávila Zaragozá is a notable inventor based in Pamplona-Navarra, Spain. He has made significant contributions to the field of biomedical research, particularly in the treatment of multiple sclerosis. His innovative approach combines established compounds to enhance therapeutic outcomes.
Latest Patents
Matías holds a patent for "Synergistic 5'-methylthioadenosine combinations." This invention relates to the use of combinations of 5'-methylthioadenosine and glatiramer acetate for the treatment of multiple sclerosis. The patent outlines a product that includes these two compounds as a combined preparation for simultaneous, separate, or sequential use in preventing and treating this debilitating condition. He has 1 patent to his name.
Career Highlights
Matías is associated with Proyecto de Biomedicina Cima, S.L., where he applies his expertise in developing innovative treatments. His work focuses on enhancing the efficacy of existing therapies through novel combinations of pharmaceutical agents.
Collaborations
He collaborates with esteemed colleagues such as Fernando José Corrales Izquierdo and Begoña Fernández Díez, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Matías Antonio Ávila Zaragozá exemplifies the spirit of innovation in biomedical research, with his patent offering promising avenues for the treatment of multiple sclerosis. His contributions are paving the way for advancements in therapeutic strategies.